Related Experiment Videos
[Function,molecular structure and gene expression of macrophage colony-stimulating factor]
Abstract:
Human urinary macrophage colony-stimulating factor (hM-CSF) is a glycoprotein with a molecular weight of 85 kDa which consists of two homologous subunits with a molecular weight of 43 kDa. It stimulates monocyte production through the stimulation of progenitor cells to differentiate to mature monocytes as well as neutrophil production through the stimulation of mature monocytes to produce granulocyte-macrophage and granulocyte CSF. It also enhances platelet production through the production of megakaryocyte potentiator (Meg-POT). Recently, proteoglycan type M-CSF has been found by our group. This type of M-CSF has a molecular weight of greater than 200 kDa and consists of a 43 kDa subunit and a 150-200 kDa subunit, the latter of which contains chondroitin sulfate glycosaminoglycan. This proteoglycan type M-CSF binds to extra-cellular matrix at the part of glycosaminoglycan. In addition to hematopoiesis-stimulating activity, M-CSF has a promoting activity on monocyte tumor-killing, osteoclast production and differentiation of cytotrophoblasts to syncytiotrophoblasts which secrete gonadotropin. M-CSF receptor (M-CSF-R) was found as a product of proto-oncogene, c-fms which consists of 972 amino acids. Mutations at Tyr 969 and Ser 301 of M-CSF-R has been found in patients with myelodysplastic syndrome and monocytic leukemia.
Insights
Human urinary macrophage colony-stimulating factor (hM-CSF) is a glycoprotein that stimulates monocyte, neutrophil, and platelet production. A novel proteoglycan form of hM-CSF binds to the extracellular matrix, influencing various cellular processes.
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Macrophage colony-stimulating factor (M-CSF) is an 85 kDa glycoprotein crucial for hematopoiesis.
- M-CSF stimulates monocyte, neutrophil, and platelet production.
- M-CSF also influences monocyte tumor-killing, osteoclast formation, and trophoblast differentiation.
Purpose of the Study:
- To characterize a newly discovered proteoglycan form of M-CSF.
- To investigate the binding properties and composition of proteoglycan M-CSF.
- To explore the diverse biological activities of M-CSF.
Main Methods:
- Biochemical analysis of M-CSF subunits and molecular weight determination.
- Characterization of proteoglycan M-CSF, including glycosaminoglycan content.
- Investigation of M-CSF binding to extracellular matrix components.
Main Results:
- A proteoglycan M-CSF form, exceeding 200 kDa, was identified.
- This proteoglycan form contains chondroitin sulfate glycosaminoglycan and binds to the extracellular matrix.
- M-CSF receptor (M-CSF-R), encoded by c-fms, was identified, with mutations linked to myelodysplastic syndrome and monocytic leukemia.
Conclusions:
- M-CSF exists in distinct forms, including a novel proteoglycan variant with extracellular matrix binding capabilities.
- M-CSF plays multifaceted roles beyond hematopoiesis, impacting immune responses and bone metabolism.
- M-CSF receptor mutations are implicated in specific hematological malignancies.